JAK2 and age-related macular degeneration: HNG treatment increased gp130 by 61.87% (P=0.007, Figure 6b) and Phospho-JAK2 by 48.05% (P=0.003, Figure 6c) in AMD cybrids compared to untreated-AMD cybrids.